Amsterdam Investigator–initiateD Absorb strategy all-comers trial (AIDA trial): A clinical evaluation comparing the efficacy and performance of ABSORB everolimus-eluting bioresorbable vascular scaffold strategy vs the XIENCE family (XIENCE PRIME or XIENCE Xpedition) everolimus-eluting coronary stent strategy in the treatment of coronary lesions in consecutive all-comers: Rationale and study design

✍ Scribed by Woudstra, Pier; Grundeken, Maik J.; Kraak, Robin P.; Hassell, Mariëlla E.C.J.; Arkenbout, E. Karin; Baan, Jan; Vis, Marije M.; Koch, Karel T.; Tijssen, Jan G.P.; Piek, Jan J.; de Winter, Robbert J.; Henriques, José P.S.; Wykrzykowska, Joanna J.

• Book ID: 122314415
• Publisher: Elsevier Science
• Year: 2014
• Tongue: English
• Weight: 813 KB
• Volume: 167
• Category: Article
• ISSN: 1097-6744
• DOI: 10.1016/j.ahj.2013.09.017